The effects of several autonomic agents on total protein, amylase, RNase, calcium, potassium, and sodium levels and also on flow rate of mouse parotid saliva were investigated during the process of evaluating the in vivo mouse parotid gland preparation as a pharmacological tool. Acetylcholine and pilocarpine were used as secretagogues and produced different sequential patterns of sodium and enzyme levels secreted in mouse parotid saliva. Additionally, propranolol treatment was able to alter amylase and sodium levels produced by pilocarpine stimulation significantly, as well as alter calcium levels produced by both acetylcholine and pilocarpine stimulation. Phentolamine treatment resulted in higher amylase levels with both acetylcholine and pilocarpine stimulation. The use of acetylcholine as a secretagogue allows one to perform in vivo anticholinergic experiments which alter flow rates without significantly altering protein or ion levels secreted in mouse parotid saliva.
Get full access to this article
View all access options for this article.
References
1.
Abe, K. and Dawes, C. (1982): Secretion of Protein by the Submandibular Glands of the Rat, Mouse and Hamster in Response to Various Parasympatho- and Sympathomimetic Drugs, J Dent Res61:1454-1457.
2.
Bobyock, E. and Chernick, W.S. (1984): Sequential Patterns of Cholinomimetic-induced Mouse Parotid Secretion: Inhibition by Atropine and H1-Receptor Antagonists , The Pharmacologist26:227.
3.
Bradford, M.M. (1976): A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding, Anal Biochem72:248-254.
4.
Chernick, W.S.; Bobyock, E.; and Digregorio, G.J. (1971): Collection and Quantitation of Mouse Salivary Secretions, J Dent Res50:165.
5.
Chernick, W.S.; Eichel, H.J.; and Barbero, G.J. (1964): Submaxillary Salivary Enzymes as a Measure of Glandular Activity in Cystic Fibrosis, J Pediat65:694-700.
6.
Das, P.K. and Parratt, J.R. (1971): Myocardial and Haemodynamic Effects of Phentolamine , Br J Pharmacol41:437-444.
7.
Denniss, A.R. and Young, J.A. (1978): Modification of Salivary Duct Electrolyte Transport in Rat and Rabbit by Physalaemin, VIP, GIP, and other Enterohormones, Pflugers Arch Europ J Physiol376:73-80.
8.
Eichel, H.J.; Conger, N.; and Chernick, W.S. (1964): Acid and Alkaline Ribonucleases of Human Parotid, Submaxillary, and Whole Saliva, Arch Biochem Biophys107:197-208.
9.
Emmelin, N. (1967a): Nervous Control of Salivary Glands. In: Handbook of Physiology. Alimentary Canal. Washington, D.C.: Am. Physiol. Soc., Sect. 6, Vol. II, chapt. 37, pp. 595-632.
10.
Emmelin, N. (1967b): Pharmacology of Salivary Glands. In: Handbook of Physiology. Alimentary Canal. Washington, D.C.: Am. Physiol. Soc., Sect . 6, Vol. II, chapt. 37, pp. 665-678.
11.
Emmelin, N. and Holmberg, J. (1967): The Presence of Beta-Receptors in the Submaxillary Gland of the Dog, Br J Pharmacol30:371-378.
12.
Emmelin, N.; Holmberg, J.; and Ohlin, P. (1965): Receptors for Catecholamines in the Submaxillary Glands of Rats, Br J Pharmacol25:134-138.
13.
Garattini, S. (1960): The Pressor Effect of Reserpine after Monoamine-Oxidase Inhibitors, Med Exp (Basel)2:252-259.
14.
Hagen, J.M. (1959): Stimulation of Secretion and Metabolism in Mouse Parotid Glands in vitro, Biochem Pharmacol2:206-214.
15.
Inoki, R.; Kudo, T.; Kotani, Y.; Oka, M.; Iwatsubo, K.; and Matsumoto, K. (1979): Mechanism of Substance P-Induced Salivary Secretion in Rats, Adv Exp Med Biol120A:409-420.
16.
Kaiser, D.; Pivetta, 0.; and Rennert, O.M. (1973): Autosomal Recessively Inherited Electrolyte Excretory Defect in the Parotid of the "Cribriform Degeneration" Mouse Mutant - Possible Analogy to Cystic Fibrosis, Life Sci15:803-810.
17.
Langer, S.Z. (1977): Presynaptic Receptors and their Role in the Regulation of Transmitter Release, Br J Pharmacol60:481-497.
18.
Mangos, J.A.; McSherry, N.R.; Nousia-Arvanitakis, S.; and Irwin, K. (1973): Secretion and Transductal Fluxes of Ions in Exocrine Glands of the Mouse, Am J Physiol225:18-24.
19.
Prichard, B.N.C. (1978): Beta-Adrenergic Receptor Blockade in Hypertension , Past, Present and Future, Br J Clin Pharmacol5 :379-399.
20.
Roberts, M.L. (1977): The in vitro Secretion of Epidermal Growth Factor by Mouse Submandibular Salivary Gland, Naunyn-Schmiedeberg's Arch Pharmacol296:301-305.
21.
Schneyer, C.A. (1965): Modification of Action of Pilocarpine by Adrenergic Blocking Agents, Proc Soc Exp Biol Med120:230-232.
22.
Schneyer, L.H.; Young, J.A.; and Schneyer, C.A. (1972): Salivary Secretion of Electrolytes, Physiol Rev52:720-777.
23.
Scriabine, A.; Torchiana, M.L.; Stavorski, J.M.; Lud-Den, C.T.; Minsker, D.H.; and Stone, C.A. (1973): Some Cardiovascular Effects of Timolol, a New Beta Adrenergic Blocking Agent, Arch Int Pharmacodyn Ther205:76-93.
24.
Smith, B.W. and Roe, J.H. (1948): A Photometric Method for the Determination of Alpha-Amylase in Blood and Urine with the Use of the Starch-Iodine Color, J Biol Chem11:53-59.
25.
Wallace, L.J. and Partlow, L.M. (1976): Alpha-Adrenergic Regulation of Secretion of Mouse Saliva Rich in Nerve Growth Factor, Proc Natl Acad Sci73:4210-4214.
26.
Watson, E.; Dowd, F.; Jacobson, K.; and Horwitz, H. (1984): Reserpinization: Effects on Parotid Gland Function , J Dent Res63:82-86.
27.
Young, J.A. and Schneyer, C.A. (1981): Composition of Saliva in Mammalia, Aust J Exp Biol Med Sci59:1-53.
28.
Young, J.A. and Van Lennep, E.W. (1979): Transport in Salivary and Salt Glands. In: Membrane Transport in Biology, G. Giebish, D.C. Tosteson , and H.H. Ussing, Eds., Vol. 4B. Berlin, Heidelberg, New York: Springer , pp. 563-674.
29.
Yu, J.H.; Burns, S.M.; and Schneyer, C.A. (1983): Salivary Secretion Induced by Substance P, Proc Soc Exp Biol Med173 :467-470.
